Van Hulzen Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,240
| Closed | -$1.14M | – | 293 |
|
|
2021
Q1 | $1.14M | Sell |
5,240
-250
| -5% | -$54.2K | 0.18% | 82 |
|
|
2020
Q4 | $634K | Sell |
5,490
-450
| -8% | -$52K | 0.1% | 120 |
|
|
2020
Q3 | $578K | Sell |
5,940
-200
| -3% | -$19.5K | 0.09% | 118 |
|
|
2020
Q2 | $754K | Sell |
6,140
-560
| -8% | -$68.8K | 0.11% | 101 |
|
|
2020
Q1 | $587K | Buy |
6,700
+665
| +11% | +$58.3K | 0.13% | 104 |
|
|
2019
Q4 | $631K | Buy |
6,035
+150
| +3% | +$15.7K | 0.12% | 121 |
|
|
2019
Q3 | $677K | Buy |
5,885
+400
| +7% | +$46K | 0.14% | 106 |
|
|
2019
Q2 | $946K | Sell |
5,485
-150
| -3% | -$25.9K | 0.21% | 83 |
|
|
2019
Q1 | $950K | Sell |
5,635
-15
| -0.3% | -$2.53K | 0.26% | 77 |
|
|
2018
Q4 | $550K | Buy |
5,650
+1,470
| +35% | +$143K | 0.16% | 99 |
|
|
2018
Q3 | $722K | Buy |
4,180
+935
| +29% | +$162K | 0.19% | 94 |
|
|
2018
Q2 | $453K | Buy |
3,245
+735
| +29% | +$103K | 0.13% | 106 |
|
|
2018
Q1 | $283K | Buy |
2,510
+230
| +10% | +$25.9K | 0.09% | 152 |
|
|
2017
Q4 | $301K | Buy |
2,280
+260
| +13% | +$34.3K | 0.09% | 154 |
|
|
2017
Q3 | $205K | Buy |
+2,020
| New | +$205K | 0.07% | 167 |
|